SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON D.C. 20549

                                   FORM 10-Q

                  QUARTERLY REPORT UNDER SECTION 13 OR 15 (d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                    For the quarter ended September 30, 2009

                         Commission File Number 0-10683

                                 HYDROMER, INC.
                                 --------------
             (Exact name of registrant as specified in its charter)
     New Jersey                                               22-2303576
----------------------                                -------------------------
(State of incorporation)                                  (I.R.S. Employer
                                                          Identification No.)

35 Industrial Pkwy, Branchburg, New Jersey                     08876-3424
------------------------------------------            -------------------------
  (Address of principal executive offices)                     (Zip Code)

Registrant's telephone number, including area code:        (908) 722-5000
                                                      -------------------------

Securities registered pursuant to Section 12 (b) of the Act: None

Securities registered pursuant to Section 12 (g) of the Act:

                         Common Stock Without Par Value
                                (Title of class)

   Indicate  by  check  mark  whether  the  registrant (1) has filed all reports
required  to  be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934  during  the  preceding  12  months  (or  for  such shorter period that the
registrant was required to file such report(s), and (2) has been subject to such
filing requirements for the past 90 days.       Yes [X]         No [ ]

   Indicate  by  check mark whether the registrant is a large accelerated filer,
an  accelerated  filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer [ ]     Accelerated filer               [ ]
Non-accelerated filer   [ ]     Smaller reporting company       [X]

   Indicate  by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Exchange Act).

Yes     [ ]      No     [X]



         Class                                 Outstanding at September 30, 2009
         -----                                 ---------------------------------
        Common                                          4,772,318
<PAGE>
                                 HYDROMER, INC.


                               INDEX TO FORM 10-Q
                               September 30, 2009

                                                                        Page No.
Part I  -  Financial Information

        # 1  Consolidated Financial Statements

                Balance Sheets - September 30, 2009 & June 30, 2009            2

                Statements of Income for the three months ended
                        September 30, 2009 and 2008                            3

                Statements of Cash Flows for the three months ended
                     September 30, 2009 and 2008                               4

                Notes to Financial Statements                                  5

        # 2  Management's Discussion and Analysis of the Financial Condition
                         and Results of Operations                             7

        # 3  Controls and Procedures 7


Part II  -  Other Information

        # 1  Legal Proceedings                                               N/A

        # 2  Change in Securities                                            N/A

        # 3  Default of  Senior Securities                                   N/A

        # 4  Submission of Motion to Vote of Security Holders                N/A

        # 5  Other Information                                               N/A

        # 6  Exhibits                                                          9


                                 EXHIBIT INDEX

Exhibit No.      Description of Exhibit
-----------      ----------------------
31.1             SEC Section 302 Certification - CEO certification            10
31.2             SEC Section 302 Certification - CFO certification            11

32.1             Certification of Manfred F. Dyck, Chief Executive Officer,
                         pursuant to 18 U.S.C. Section 1350                   12

32.2             Certification of Robert Y. Lee, Chief Financial Officer,
                         pursuant to 18 U.S.C. Section 1350                   12

                                       1
<PAGE>

PART I - CONSOLIDATED FINANCIAL STATEMENTS
ITEM # 1

                   HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
                          CONSOLIDATED BALANCE SHEETS

<TABLE>
<S>                                                                     <C>                                      <C>

                                                                       September 30,                   June 30,
                                                                          2009                          2009
                                                                        UNAUDITED                      AUDITED
ASSETS
Current Assets:
         Cash and cash equivalents                                $          1,102,636       $             1,585,765
         Short-term investments                                                440,000                       450,000
         Trade receivables less allowance for doubtful accounts
                of $40,120 and $57,741 as of September 30, 2009
                and June 30, 2009, respectively                              1,081,948                     1,058,978
        Inventory                                                              621,219                       615,849
        Prepaid expenses                                                       161,348                       204,280
        Deferred tax asset                                                       8,976                         8,976
        Other                                                                    8,554                         8,968
---------------------------------------------------------------------------------------------------------------------
Total Current Assets                                                         3,424,681                     3,932,816
---------------------------------------------------------------------------------------------------------------------

Property and equipment, net                                                  3,140,451                     3,135,017
Deferred tax asset, non-current                                                698,195                       521,986
Intangible assets, net                                                         778,170                       740,426
---------------------------------------------------------------------------------------------------------------------
Total Assets                                                      $          8,041,497       $             8,330,245
---------------------------------------------------------------------------------------------------------------------

LIABILITIES AND STOCKHOLDERS' EQUITY
Current Liabilities:
        Accounts payable                                          $            474,723       $               380,838
        Accrued expenses                                                       297,117                       341,088
        Current portion of capital lease                                        14,473                        14,473
        Current portion of deferred revenue                                     85,965                        82,132
        Current portion of mortgage payable                                     46,371                        45,696
        Income tax payable                                                      15,891                        75,891
---------------------------------------------------------------------------------------------------------------------
Total Current Liabilities                                                      934,540                       940,118
---------------------------------------------------------------------------------------------------------------------
Deferred tax liability                                                         284,503                       285,858
Long-term portion of capital lease                                              46,646                        50,258
Long-term portion of deferred revenue                                          167,154                       161,019
Long-term portion of mortgage payable                                        2,808,104                     2,820,055
---------------------------------------------------------------------------------------------------------------------
Total Liabilities                                                            4,240,947                     4,257,308
---------------------------------------------------------------------------------------------------------------------

Stockholders' Equity
        Preferred stock - no par value, authorized
                1,000,000 shares, no shares issued and outstanding               -                              -
        Common stock  -  no  par  value, authorized 15,000,000 shares;
                4,783,235 shares issued and 4,772,318 shares
                outstanding as of September 30, 2009 and June 30,2009       3,721,815                      3,721,815
Contributed capital                                                           633,150                        633,150
Accumulated deficit                                                         (548,275)                       (275,888)
Treasury stock, 10,917 common shares at cost                                  (6,140)                         (6,140)
---------------------------------------------------------------------------------------------------------------------
Total Stockholders' Equity                                                  3,800,550                      4,072,937
---------------------------------------------------------------------------------------------------------------------
Total Liabilities and Stockholders' Equity                      $           8,041,497        $             8,330,245
---------------------------------------------------------------------------------------------------------------------
</TABLE>







                                       2
<PAGE>

                   HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
                       CONSOLIDATED STATEMENTS OF INCOME



<TABLE>
<S>                                                        <C>                     <C>

                                                                       Three Months Ended
                                                                          September 30,
                                                                 2009                  2008
                                                              UNAUDITED              UNAUDITED
-------------                                              --------------------------------------
REVENUES
  Sale of products                                         $    1,181,704          $    1,118,068
  Service revenues                                                299,792                 514,326
  Royalties and contract revenues                                 228,075                 403,575
-----------------------------------------------            --------------------------------------
TOTAL REVENUES                                                  1,709,571               2,035,969
-----------------------------------------------            --------------------------------------

EXPENSES
  Cost of Sales                                                   840,194                 792,318
  Operating Expenses                                            1,266,360               1,153,014
  Other Expenses                                                   51,614                  40,651
  (Benefit from) Provision for Income Taxes                      (176,209)                  7,680
-----------------------------------------------            --------------------------------------
        TOTAL EXPENSES                                          1,981,959               1,993,663
-----------------------------------------------            --------------------------------------
        NET (LOSS) INCOME                                  $     (272,388)         $       42,306
-----------------------------------------------            --------------------------------------
        (Loss) Earnings Per Common Share                   $        (0.06)         $         0.01
        Diluted (Loss) Earnings Per Common Share                    (0.06)                   0.01
Weighted Average Number of
    Common Shares Outstanding                                   4,772,318               4,772,318
    Common Shares Outstanding assuming dilution                 4,772,318               4,886,318
</TABLE>




      There was no impact to earnings per share from dilutive securities.
       For the 2009 period, the resultant would have been anti-dilutive.









                                       3

<PAGE>
                   HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY
                     CONSOLIDATED STATEMENTS OF CASH FLOWS

<TABLE>
<S>                                                                           <C>              <C>
                                                                                Three months Ended
                                                                                  September 30,
                                                                              2009            2008
                                                                           UNAUDITED        UNAUDITED
--------------------------------------------------------------------------------------------------------
CASH FLOWS FROM OPERATING ACTIVITIES:
    Net (Loss) Income                                                   $   (272,388)    $   42,306
    Adjustments to reconcile net (loss) income to net cash
    used for operating activities
        Depreciation and amortization                                        101,428        107,475
        Deferred income taxes                                               (177,564)         1,652
        Changes in Assets and Liabilities:
          Trade receivables                                                  (22,970)       (23,657)
          Inventory                                                           (5,370)       (21,572)
          Prepaid expenses                                                    42,932         (1,088)
          Other assets                                                           414         (1,524)
          Accounts payable and accrued liabilities                            49,914       (176,809)
          Deferred income                                                      9,968         27,129
          Income taxes payable                                               (60,000)         6,028
------------------------------------------------------------------------------------------------------

                Net Cash Used for Operating Activities                      (333,636)       (40,060)

------------------------------------------------------------------------------------------------------

CASH FLOWS FROM INVESTING ACTIVITIES:
    Cash purchases of property and equipment                                 (65,010)       (46,611)
    Cash payments on patents and trademarks                                  (83,207)      (108,812)
    Redemption of matured short-term investments                             260,000             -.
    Cash purchases of short-term investments                                (250,000)            -.
------------------------------------------------------------------------------------------------------

                Net Cash Used for Investing Activities                      (138,217)      (155,423)

------------------------------------------------------------------------------------------------------

CASH FLOWS FROM FINANCING ACTIVITIES:
    Net repayments toward Line of Credit                                         -.        (289,973)
    Proceeds from long-term borrowings                                           -.       2,900,000
    Repayment of long-term borrowings                                        (11,276)    (1,880,302)
------------------------------------------------------------------------------------------------------


                Net Cash (Used for) Provided by Financing Activities         (11,276)       729,725

------------------------------------------------------------------------------------------------------

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS:                       (483,129)       534,242
Cash and Cash Equivalents at Beginning of Period                           1,585,765        108,403
------------------------------------------------------------------------------------------------------

Cash and Cash Equivalents at End of Period                             $   1,102,636    $   642,645
------------------------------------------------------------------------------------------------------

</TABLE>






                                       4

<PAGE>

                   HYDROMER, INC. AND CONSOLIDATED SUBSIDIARY

                   Notes to Consolidated Financial Statements

In  the  opinion  of management, the accompanying unaudited financial statements
include  all adjustments (consisting of only normal adjustments) necessary for a
fair   presentation   of   the   results   for   the  interim  periods.  Certain
reclassifications  have  been  made  to  the  previous year's results to present
comparable financial statements.

New Accounting Pronouncements
-----------------------------

Effective  July  1, 2009, the Company adopted the Financial Accounting Standards
Board  ("FASB")  Accounting  Standards  Codification  ("ASC")  105-10, Generally
Accepted Accounting Principles -- Overall ("ASC 105-10"). ASC 105-10 establishes
the FASB Accounting Standards Codification (the "Codification") as the source of
authoritative  accounting  principles  recognized  by  the FASB to be applied by
nongovernmental   entities   in  the  preparation  of  financial  statements  in
conformity  with  U.S.  GAAP.  Rules  and interpretive releases of the SEC under
authority of federal securities laws are also sources of authoritative U.S. GAAP
for SEC registrants. All guidance contained in the Codification carries an equal
level  of authority. The Codification superseded all existing non-SEC accounting
and   reporting  standards.  All  other  non-grandfathered,  non-SEC  accounting
literature  not included in the Codification is non-authoritative. The FASB will
not  issue  new  standards  in  the  form of Statements, FASB Staff Positions or
Emerging  Issues  Task  Force  Abstracts.  Instead,  it  will  issue  Accounting
Standards  Updates ("ASUs"). The FASB will not consider ASUs as authoritative in
their  own  right.  ASUs  will  serve  only  to update the Codification, provide
background  information about the guidance and provide the bases for conclusions
on  the  change(s)  in  the  Codification.  References  made  to  FASB  guidance
throughout this document have been updated for the Codification.

Effective  July  1,  2008,  the  Company  adopted  FASB  ASC  820-10, Fair Value
Measurements  and  Disclosures  --  Overall  ("ASC  820-10") with respect to its
financial  assets  and  liabilities.  In  February 2008, the FASB issued updated
guidance   related  to  fair  value  measurements,  which  is  included  in  the
Codification  in  ASC  820-10-55,  Fair  Value  Measurements  and Disclosures --
Overall  --  Implementation  Guidance  and  Illustrations.  The updated guidance
provided  a  one  year  deferral  of  the  effective  date  of  ASC  820-10  for
non-financial  assets  and  non-financial  liabilities,  except  those  that are
recognized  or  disclosed  in  the  financial  statements at fair value at least
annually.  Therefore,  the  Company  adopted  the  provisions  of ASC 820-10 for
non-financial  assets  and non-financial liabilities effective July 1, 2009, and
such  adoption  did  not  have  a  material  impact  on the Company's results of
operations or financial condition.

Effective  July  1,  2009,  the  Company  adopted FASB ASC 820-10-65, Fair Value
Measurements  and  Disclosures  -- Overall -- Transition and Open Effective Date
Information  ("ASC  820-10-65").  ASC 820-10-65 provides additional guidance for
estimating fair value in accordance with ASC 820-10 when the volume and level of
activity  for  an asset or liability have significantly decreased. ASC 820-10-65
also  includes guidance on identifying circumstances that indicate a transaction
is  not  orderly.  The  adoption  of ASC 820-10-65 did not have an impact on the
Company's consolidated results of operations or financial condition.

Effective  July  1,  2009,  the  Company  adopted  FASB ASC 825-10-65, Financial
Instruments  --  Overall -- Transition and Open Effective Date Information ("ASC
825-10-65").  ASC  825-10-65 amends ASC 825-10 to require disclosures about fair
value  of  financial  instruments  in interim financial statements as well as in
annual  financial  statements  and  also  amends  ASC  270-10  to  require those
disclosures  in  all interim financial statements. The adoption of ASC 825-10-65
did  not  have  a  material  impact  on  the  Company's results of operations or
financial condition.

FAIR VALUE
----------

In  accordance  with FASB ASC 820 "Fair Value Measurements and Disclosures", the
following  table represents the Company's fair value hierarchy for its financial
assets  and  liabilities  measured  at  fair  value  on  a recurring basis as of
September 30, 2009:

                                       5


<TABLE>
                            <S>              <C>         <C>        <C>            <C>


                           ---------------- ------------ ----------- ----------- ------------
                                              Level 1     Level 2     Level 3       Total
                                              -------     -------     -------       -----
                           ASSETS
                               Investments  $  440,000                           $  440,000
                                               -------                              -------
                           Total Assets     $  440,000       -           -       $  440,000
                                               =======                              =======

                           LIABILITIES - n/a      -          -           -            -
                           ---------------- ------------ ----------- ----------- ------------
</TABLE>

Some  of the Company's financial instruments are not measured at fair value on a
recurring  basis  but are recorded at amounts that approximate fair value due to
their   liquid  or  short-term  nature,  such  as  cash  and  cash  equivalents,
receivables and payables.  The carrying amount of the Company's note obligation
approximates its fair value,  as the terms of the note is consistent with terms
available in the market for instruments with similar risk.

Segment Reporting:
------------------
The  Company  operates  two primary business segments. The Company evaluates the
segments  by  revenues,  total  expenses  and  earnings  before taxes. Corporate
Overhead  is  excluded  from  the  business  segments  as  to  not  distort  the
contribution  of  each  segment.  These segments are the lowest levels for which
identifiable  cash  flows  are  largely  independent  of the cash flows of other
assets and liabilities.

The results for the three months ended September 30, by segment are:
<TABLE>
<S>                   <C>                         <C>               <C>               <C>

                                              Polymer       Medical     Corporate
                                             Research      Products      Overhead        Total
2009
Revenues                                     962,136        747,435                    1,709,571
Expenses                                    (966,814)      (788,962)     (402,392)    (2,158,168)
                                            ---------      ---------     ---------    -----------
     Pre-tax Loss                             (4,678)       (41,527)     (402,392)      (448,597)
                                              =======       ========     =========      =========

-------------------------------------------------------------------------------------------------

2008
Revenues                                   1,211,423        824,546                    2,035,969
Expenses                                    (796,297)      (783,640)     (406,046)    (1,985,983)
                                            ---------      ---------     ---------    -----------
     Pre-tax Income (Loss)                   415,126         40,906      (406,046)        49,986
                                             =======         ======      =========        =======
</TABLE>


Geographic revenues were as follows for the three months ended September 30,

                                                             2009      2008
                                                             ----      ----
                                 Domestic                     76%       82%
                                 Foreign                      24%       18%


                                       6
<PAGE>
ITEM #2

                  MANAGEMENT'S DISCUSSION AND ANALYSIS OF THE
                 FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Results of Operations
---------------------

The Company's revenues for the quarter ended September 30, 2009 were $1,709,571,
16.0%  lower than the $2,035,969 for the same period the previous year. Revenues
are  comprised  of  the  sale  of Products and Services and Royalty and Contract
payments.

      Product  sales were $1,181,704 for the quarter ended September 30, 2009 as
      compared  to  $1,118,068  for  the  same period the year before, a $63,636
      increase  or  5.7%.  Sales during the quarter ended September 30, 2008 was
      negatively  impacted  by  third party parts availability and sterilization
      issues.  Although the Company was able to rebound from those issues during
      the  months  following,  sales during the quarter ended September 30, 2009
      was  impacted  by  $217,065  from  the transfer price agreement with Merit
      Medical  Systems,  Inc  ("Merit").  (The  Company  sold two of its medical
      device  product  lines  to  Merit in February 2009, and until October 2009
      manufactured  these  products solely for Merit at a predetermined transfer
      rate  which  was  lower  than that the Company was previously able to sell
      such products for).

      Services  revenues  for  the  three  months  ended  September 30, 2009 was
      $299,792  or  $214,534  lower  (41.7%) than the $514,326 the corresponding
      period  the  year  before.  The  conversion  of  a  customer from contract
      coatings  servicing  to  product  sales  accounted  for  $121,915 of lower
      services  revenues  this quarter. Also included in the prior year's period
      was  $52,500  in  R&D  services.  That  project was completed in the prior
      fiscal year.

      Royalty  and Contract revenues include royalties received and the periodic
      recurring  payments  from  license,  stand  still and other agreements for
      other than product and services. Included in Royalty and Contract revenues
      are revenues from support and supply agreements. Some of the royalties and
      support  fees  are  based on the net sales of the final item (to which the
      Hydromer technology is applied to) and are subject to the reporting of our
      customers.  For the quarter ended September 30, 2009, Royalty and Contract
      revenues  were  $228,075, compared to $403,575 the same period a year ago.
      The  cancellation  of a supply and support agreement of $100,000 per month
      in January 2009, replaced by a similar agreement at $35,000 per month, was
      the primary factor behind the difference.

      As  of  September  30,  2009,  our open sales order book was approximately
      $793,000.  Although  some  of  the  sales orders can be cancelled prior to
      production,   the   Company   is   of  the  opinion  that  no  substantial
      cancellations  will  occur.  This  value  is  lower than previous reported
      periods  due  to  the sale of product lines to Merit and the conclusion of
      the production transfer period.

Total  Expenses  for  the  quarter  ended  September 30, 2009 were $1,981,959 as
compared with $1,993,663 the year before, a 0.6% decrease.

      The  Company's  Cost  of  Goods  Sold  was  $840,194 for the quarter ended
      September  30,  2009  as  compared with $792,318 the year prior, higher by
      6.0%. Higher product sales volume and higher sterilization volume were the
      primary reasons for the increase.

      Operating  expenses  were  $1,266,360  for the quarter ended September 30,
      2009 as compared with $1,153,014 the year before, up $113,346 or 9.8%. The
      increased  international  focus  in  our  T-HEXX  Animal  Health business,
      including  a  dedicated  product  manager,  added tradeshow promotions and
      marketing  expenses  added  $62,076 in higher costs in the current period.
      One time legal fees of $30,668 relating to the freedom to market clearance
      review  was  incurred  during the period. Such legal fees allows for a new
      Hydrogel  product  launch  with  legal  clearance. In addition, during the
      quarter  $22,804  was  spent  on animal clinical studies on our soon to be
      launched  Dragonhyde  Hoof Bath concentrate. All of the incremental spends
      this quarter are directly in relation towards future revenue sources.

      Interest  expense,  interest income and other income are included in Other
      Expenses.  Interest  expense for the three months ended September 30, 2009
      and  September  30, 2008 were $53,035 and $46,074, respectively, up due to
      the  mortgage  refinance  in  September 2008 which provided the Company an

                                       7
<PAGE>
      additional  $1  million  in  cash,  used  in  part to payoff and close the
      line-of-credit facility. Interest expense in 2008 included interest on the
      line-of-credit facility.

A  net  loss  of  $272,388  ($0.06  per share) is reported for the quarter ended
September  30,  2009  as compared to net income of $42,306 ($0.01 per share) the
year before.

      The  cancellation  and  subsequent  entering  of a lower valued supply and
      support  agreement  impacted operating income by $195,000 as compared with
      the  prior year. The transfer price agreement impacted operating income by
      another  $217,065.  An income tax benefit of $176,209 was recorded for the
      quarter.

      Re-investment   expenditures  of  Research  and  Development  and  patents
      expenditures   accounted  for  approximately  $234,218  or  18.5%  of  the
      operating expenses.


Financial Condition
-------------------

Working  capital  decreased $502,557 during the three months ended September 30,
2009.

Net  operating  activities  used  $333,636  during  the three month period ended
September 30, 2009.

      The  net  loss  as  adjusted for non-cash expenses, used $348,524 in cash.
      Income taxes paid during the quarter was $60,000.

Investing  activities used $138,217 and financing activities used $11,276 during
the three months ended September 30, 2009.

      Investing  activities  for  the  three  months  ended  September  30, 2009
      included   $65,010  for  capital  expenditures  and  $83,207  towards  the
      Company's  patent  estate.  $260,000 in short-term investments matured and
      $250,000 was reinvested. Under financing activities, the principal portion
      of debt servicing of the mortgage utilized $11,276 in cash.

As  previously  reported, until replacement income is achieved, the cancellation
of  the  $100,000 per month Supply and Support Agreement and the sale of product
lines  to  Merit,  with  the  sales proceeds representing the future cash flows,
pushes  the  Company  into  an  operating loss position for the near future. The
timing    of   new   revenues,   including   that   from   its   anti-microbial,
anti-thrombogenic and cell mitosis technologies and new T-HEXX product lines and
broaden  T-HEXX  market  penetration,  are  in  varying  stages,  though  it  is
management's  expectations  that anything of significance, in the aggregate, are
at  least  a  year  away.  The  Company  has  a strong balance sheet to meet its
required debt servicing.

ITEM # 3

Disclosure Controls and Procedures
----------------------------------

   As  of  the  period  covered  by  this  report,  the  Company  carried out an
evaluation,  under the supervision and with the participation of our management,
including  the  Chief  Executive  Officer  and President and the Chief Financial
Officer,  of  the  effectiveness  of  the design and operation of the disclosure
controls and procedures.

    Based  upon this evaluation, our Chief Executive Officer and Chief Financial
Officer  concluded  that,  our disclosure controls and procedures were effective
and  that there were no changes to our Company's internal control over financial
reporting  that  have materially affected, or is reasonably likely to materially
affect the Company's internal control over financial reporting during the period
covered by the Company's quarterly report.

PART II - OTHER INFORMATION

   The Company operates entirely from its sole location at 35 Industrial Parkway
in  Branchburg,  New  Jersey,  an owned facility secured by a mortgage through a
bank.

   The  existing  facility will be adequate for the Company's operations for the
foreseeable future.
                                       8
<PAGE>
ITEM # 6. Exhibits
<TABLE>
        <S>                     <C>

       Exhibit No.        Description
       -----------        -----------
          31.1            Rule 13a-14(a) Certification of Chief Executive
                                Officer and President
          31.2            Rule  13a-14(a) Certification of Vice President of
                                Finance and  Chief  Financial Officer
          32.1            Section 1350 Certification of Chief  Executive
                                Officer  and  Chairman, President
          32.2            Section 1350 Certification of Chief Financial Officer
                                and Vice President of Finance
</TABLE>

                                      9
<PAGE>

                                   SIGNATURES



Pursuant  to  the  requirements  of  the  Securities  Exchange  Act of 1934, the
registrant  has  duly  caused  this  report  to  be  signed on his behalf by the
undersigned thereunto duly authorized.

                                                       HYDROMER, INC.

                                                       /s/ Robert Y. Lee, VP
                                                       ---------------------
                                                       Robert Y. Lee
                                                       Chief Financial Officer



DATE: November 13, 2009




<PAGE>
                                  EXHIBIT 31.1

I, Manfred F. Dyck, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Hydromer, Inc.;

2. Based on my  knowledge, this quarterly  report does not contain any untrue
   statement of a material fact or omit to state a material fact necessary to
   make the statements  made, in light of the circumstances under which such
   statements were made, not misleading with respect to the period covered by
   this quarterly report;

3. Based on my knowledge, the financial statements, and other  financial
   information included in this quarterly report, fairly present in all material
   respects the financial condition, results of operations and cash flows of the
   registrant as of, and for, the periods presented in this quarterly report;

4. The  registrant's  other  certifying  officer, Mr. Robert Y. Lee and I am
   responsible for  establishing  and maintaining disclosure controls and
   procedures (as defined in Exchange  Act Rules 13a-15(e) and 15d-15(e)) and
   internal control over financial reporting (as defined in Exchange Act Rules
   13a-15(f) and 15d-15(f) for the registrant and have:

      a) designed such disclosure controls and procedures, or caused such
        disclosure controls and procedures to be designed under our supervision,
        to  ensure that  material information relating to the registrant,
        including its consolidated subsidiaries, is made known to us by others
        within those entities, particularly  during the period in which this
        quarterly report is being prepared;

      b) designed such internal controls over financial reporting, or caused
        such internal controls over financial reporting to be designed under our
        supervision,  to provide reasonable assurances regarding the reliability
        of  financial  reporting and the preparation of financial statements for
        external  purposes  in  accordance  with  generally  accepted accounting
        principles

      c) evaluated  the effectiveness of the registrant's disclosure controls
         and procedures and presented in this report our conclusions about the
         effectiveness of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

      d) disclosed in this report any change in the registrant's internal
         control over financial reporting that occurred during the registrant's
         most recent fiscal quarter (the registrant's fourth fiscal quarter in
         case of an annual report) that has materially affected, or is
         reasonably likely to materially affect, the registrant's internal
         control over financial reporting;

5. The registrant's other certifying officer, Mr. Robert Y. Lee and I have
   disclosed, based on our most recent evaluation, to the registrant's auditors
   and the audit committee of registrant's board of directors (or persons
   performing the equivalent functions):

      a) all significant deficiencies in the design or operation of internal
         controls which could adversely affect the registrant's  ability to
         record, process, summarize and report financial data and have
         identified for the registrant's auditors any material weaknesses in
         internal controls; and

      b) any fraud, whether or not material, that involves management or other
         employees who have a significant role in the registrant's internal
         controls; and

6. The registrant's other certifying officer, Mr. Robert Y. Lee and I have
   indicated in this quarterly report whether there were significant changes in
   internal controls or in other factors that could significantly affect
   internal controls subsequent to the date of our most recent evaluation,
   including any corrective actions with regard to significant deficiencies and
   material weaknesses.

Date: November 13, 2009


/s/  Manfred F. Dyck
------------------------------------
Manfred F. Dyck, President and CEO

                                       10
<PAGE>
                                  EXHIBIT 31.2

I, Robert Y. Lee, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Hydromer, Inc.;

2. Based on my knowledge, this quarterly report does not contain any untrue
   statement of a material fact or omit to state a material fact necessary to
   make the statements made, in light of the circumstances under which such
   statements were made, not misleading with respect to the period covered by
   this quarterly report;

3. Based on my knowledge, the financial statements, and other financial
   information included in this quarterly report, fairly present in all material
   respects the financial condition, results of operations and cash flows of the
   registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officer, Mr. Manfred F. Dyck and I am
   responsible for  establishing and maintaining disclosure controls and
   procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
   internal control over  financial reporting (as defined in Exchange Act Rules
   13a-15(f) and 15d-15(f) for the registrant and have:

      a) designed such disclosure controls and procedures, or caused such
         disclosure controls and procedures to be designed under our
         supervision, to ensure that material information relating to the
         registrant, including its consolidated subsidiaries, is made known to
         us by others within  those  entities,  particularly  during  the period
         in which this quarterly report is being prepared;

      b) designed such internal controls over financial reporting, or caused
         such internal controls over financial reporting to be designed under
         our supervision, to provide reasonable assurances regarding the
         reliability of financial reporting and the preparation of financial
         statements for external purposes in accordance with generally accepted
         accounting principles

      c) evaluated the effectiveness of the registrant's disclosure controls and
         procedures and presented in this report our conclusions about the
         effectiveness of the disclosure controls and procedures, as of the end
         of the period covered by this report based on such evaluation; and

      d) disclosed in this report any change in the registrant's internal
         control over financial reporting that occurred during the registrant's
         most recent fiscal quarter (the registrant's fourth fiscal quarter in
         case of an annual report) that has materially affected, or is
         reasonably likely to materially affect, the registrant's internal
         control over financial reporting;

5. The registrant's other certifying officer, Mr. Manfred F. Dyck and I have
   disclosed, based on our most recent evaluation, to the registrant's auditors
   and the audit committee of registrant's board of directors (or persons
   performing the equivalent functions):

      a) all significant deficiencies in the design or operation of internal
         controls which could adversely affect the registrant's ability to
         record, process, summarize and report financial data and have
         identified for the registrant's auditors any material weaknesses in
         internal controls; and

      b) any  fraud, whether or not material, that involves management or other
         employees who have a significant role in the registrant's internal
         controls; and

6. The registrant's other certifying officer, Mr. Manfred F. Dyck and I have
   indicated in this quarterly report whether there were significant changes in
   internal controls or in other factors that could significantly affect
   internal controls subsequent to the date of our most recent evaluation,
   including any corrective actions with regard to significant deficiencies and
   material weaknesses.

Date: November 13, 2009

/s/ Robert Y. Lee, VP
------------------------------------------
Robert Y. Lee, Vice President of Finance and CFO


                                       11
<PAGE>

                                  EXHIBIT 32.1

                    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                                  PURSUANT TO
                            18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I,  Manfred  F.  Dyck,  certify,  pursuant to 18 U.S.C. Section 1350, as adopted
pursuant  to  Section  906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report  of  Hydromer, Inc. on Form 10-Q for the three months ended September 30,
2009  fully  complies  with  the  requirements  of Section 13(a) or 15(d) of the
Securities  Exchange  Act  of 1934 and that information contained in such report
fairly  presents in all material respects the financial condition and results of
operations of Hydromer, Inc.
<TABLE>
<S>                                     <C>

Date: November 13, 2009                By:  /s/  Manfred F. Dyck
                                            ---------------------------------------------------
                                                 Manfred F. Dyck
                                                 Chairman, President and Chief Executive Officer
</TABLE>





                                  EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                                  PURSUANT TO
                            18 U.S.C. SECTION 1350,

                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


I,  Robert  Y.  Lee,  certify,  pursuant  to  18 U.S.C. Section 1350, as adopted
pursuant  to  Section  906 of the Sarbanes-Oxley Act of 2002, that the Quarterly
Report  of  Hydromer, Inc. on Form 10-Q for the three months ended September 30,
2009  fully  complies  with  the  requirements  of Section 13(a) or 15(d) of the
Securities  Exchange  Act  of 1934 and that information contained in such report
fairly  presents in all material respects the financial condition and results of
operations of Hydromer, Inc.
<TABLE>
<S>                                     <C>

Date:  November 13, 2009                By: /s/ Robert Y. Lee, VP
                                            -------------------------------------------------------
                                                Robert Y. Lee
                                                Chief Financial Officer and Vice President of Finance
</TABLE>






                                       12